BioCardia Warrants

YTD

ALL

Why Robinhood?

You can watch BCDAW and buy or sell other stocks, ETFs, and their options commission-free!

About BCDAW

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers.

CEO

Peter Alan Altman, PhD

CEOPeter Alan Altman, PhD

Employees

—

Employees—

Headquarters

Sunnyvale, California

HeadquartersSunnyvale, California

Founded

1994

Founded1994

Employees

—

Employees—

BCDAW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

13.23K

Average volume13.23K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.90

52 Week high$0.90

52 Week low

$0.0059

52 Week low$0.0059